GE Vernova stock today: Why GEV is holding near $665 as Fed minutes loom

GE Vernova stock today: Why GEV is holding near $665 as Fed minutes loom

NEW YORK, December 30, 2025, 11:25 ET — Regular session

  • GE Vernova shares were slightly higher in morning trading, outperforming a softer broader tape in thin year-end volumes.
  • A fresh analyst note flagged GE Vernova’s acquisition-led grid push, while highlighting a premium valuation.
  • Investors are watching the Fed minutes due later Tuesday and the company’s Jan. 5 dividend record date.

GE Vernova Inc. shares were up about 0.2% at $664.52 in morning trade on Tuesday. The stock has traded between $660.91 and $667.99 so far in the session.

The power-equipment maker has become a high-profile way to play rising electricity demand tied to data centers and grid spending. That has put the stock in a high-valuation cohort where shifts in interest-rate expectations can drive day-to-day moves.

U.S. stocks edged lower in thin holiday trading, with investors waiting for minutes from the Federal Reserve’s Dec. 9-10 meeting due later Tuesday. “I wouldn’t try to make too much out of anything that happens in a holiday-shortened week,” said Art Hogan, chief market strategist at B Riley Wealth. Reuters

With U.S. markets closed on Thursday for New Year’s Day, traders have pointed to patchy liquidity and outsized moves on modest flows. That can leave single stocks reacting more to positioning than fresh fundamentals.

In a note published Tuesday, Tanvi Sarawagi at Zacks Investment Research said GE Vernova is using acquisitions to deepen its electrification and grid-infrastructure reach, highlighting its planned buyout of the remaining stake in transformer maker Prolec GE alongside smaller deals. Sarawagi also wrote that the stock trades at roughly 50 times forward earnings, well above an industry average near 21.

A forward price-to-earnings ratio, or forward P/E, is a quick gauge of how much investors are paying for each dollar of expected profit. The premium means investors will want to see orders convert into earnings and cash, not just headline demand.

GE Vernova earlier this month doubled its quarterly dividend to 50 cents a share and lifted its share repurchase authorization to $10 billion, the company said. The dividend is payable on Feb. 2 to shareholders of record on Jan. 5, and the company said it had used $3.3 billion of its buyback authorization as of Dec. 3.

Those shareholder-return plans have helped keep the stock supported into year-end, even as investors debate how quickly AI-related power demand will translate into sustained capital spending across the grid.

Analysts expect GE Vernova to earn $2.99 per share for its fiscal fourth quarter, according to Barchart, which also pegged the company’s market value at about $180 billion. Barchart said the stock is up roughly 93% over the past 52 weeks.

Investors are likely to keep one eye on the Fed minutes and another on GE Vernova’s next earnings update for an order backlog — work booked but not yet delivered — and cash-flow targets. The Jan. 5 dividend record date is the next near-term corporate milestone.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap Holdings

NYSE: AER 92/100
#2 BUY

Uber Technologies

NYSE: UBER 90/100
#3 BUY

Taiwan Semiconductor Manufacturing

NYSE: TSM 89/100
#4 ACCUMULATE

dLocal

NASDAQ: DLO 86/100
#5 ACCUMULATE

Tapestry

NYSE: TPR 84/100
View full portfolio
Editorial model selection. Not personalised advice.
Why Caterpillar stock is riding an AI data-center generator boom
Previous Story

Why Caterpillar stock is riding an AI data-center generator boom

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade
Next Story

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade